This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Endocyte Inc (ECYT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 45.53M 52.85M 34.00M 61.35M
Receivables 706.40K 6.35M 5.69M 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 652.51K 496.34K 3.30M 548.32K
Total Current Assets 127.04M 133.33M 184.82M 129.76M
Property, Plant & Equipment, Gross 7.48M 6.62M 5.30M 3.16M
Accumulated Depreciation & Depletion 3.51M 2.78M 2.13M 2.05M
Property, Plant & Equipment, Net 3.97M 3.84M 3.17M 1.11M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 81.79M 25.69M 26.09M 811.23K
Total Non-Current Assets 85.76M 29.53M 29.25M 1.92M
Liabilities & Shareholder Equity
Total Assets 212.80M 162.86M 214.08M 131.68M
Accounts Payable 1.23M 5.44M 3.65M 2.13M
Short Term Debt 0.00 0.00 12.65K 0.00
Other Current Liabilities 3.14K 18.17K 0.00 1.54M
Total Current Liabilities 6.88M 73.66M 62.47M 5.47M
Long Term Debt 0.00 0.00 0.00 12.83M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 912.26K 965.40K 51.99M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 912.26K 965.40K 52.04M 12.83M
Total Liabilities 7.80M 74.63M 114.51M 18.30M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 205.00M 88.23M 99.57M 113.37M
Common Par 41.78K 36.16K 35.92K 35.78K
Additional Paid In Capital 373.57M 262.06M 255.36M 251.94M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -168.47M -173.92M -155.89M -138.60M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -143.93K 56.69K 72.75K -6.26K
Total Capitalization 205.00M 88.23M 99.57M 126.21M
Total Equity 205.00M 88.23M 99.57M 113.37M
Total Liabilities & Stock Equity 212.80M 162.86M 214.08M 131.68M
Total Common Shares Outstanding 41.78M 36.16M 35.92M 35.78M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 40.24M 36.04M 35.86M 29.00M
Diluted Weighted Shares Outstanding 41.76M 36.04M 35.86M 29.00M
Number of Employees 81 91 71 61
Number of Part-Time Employees 0 0 0 0
ECYT News

Analysts Ratings for ECYT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 1 1
Hold 2 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ECYT ANALYST REPORT

Brokerage Partners

ECYT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs